Research program at Uppsala University

The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.

Share on social networks:

Other projects that may interest you

EVPA Knowledge Centre 2018

i4c gives support to EVPA Knowledge Center. It is a knowledge center about Venture Philanthropy and social investment, mainly in Europe. It gives information about subjects related to Venture Philanthropy…
see project
Aura fundación

Savings Plans 2024

Since 2007, Invest for children has been donating a monthly sum for the savings plans for employees with intellectual disabilities. 25 employees have been the beneficiaries of these plans contracted…
see project